Impaired fluidity and oxidizability of HDL hydrophobic core and amphipathic surface in dyslipidemic men

Metabolism: Clinical and Experimental

Volumn 62, Issue 7, 2013, Pages 986-991

  Cazzola, Roberta ^a   Cassani, Erica ^b   Barichella, Michela ^b   Cestaro, Benvenuto ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b PARKINSON INSTITUTE   (Italy)

Author keywords

HDL function; Lipid peroxidation; Mixed dyslipidemia

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; MONOUNSATURATED FATTY ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHEMICAL COMPOSITION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYDROPHOBICITY; INSULIN RESISTANCE; LIPID PEROXIDATION; MALE; OBESITY; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY;

ADULT; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; ITALY; KINETICS; LIPID PEROXIDATION; LIPOPROTEINS, HDL; MALE; MALONDIALDEHYDE; MEMBRANE FLUIDITY; MIDDLE AGED; OBESITY; OVERWEIGHT; OXIDATION-REDUCTION; PHYSICOCHEMICAL PHENOMENA; RISK; SURFACE PROPERTIES;

EID: 84879553808     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.01.012     Document Type: Article

References (35)

1. A. Kontush, and M.J. Chapman Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis Pharmacol Rev 58 2006 342 374
2. A. Mertens, and P. Holvoet Oxidized LDL and HDL: antagonists in atherothrombosis FASEB J 15 2001 2073 2084
3. V.W. Bowry, K.K. Stanley, and R. Stocker High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors Proc Natl Acad Sci U S A 89 1992 10316 10320
4. J.M. Proudfoot, A.E. Barden, and W.M. Loke HDL is the major lipoprotein carrier of plasma F2-isoprostanes J Lipid Res 50 2009 716 722
5. B. Garner, A.R. Waldeck, and P.K. Witting Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII J Biol Chem 273 1998 6088 6095
6. J. Christison, A. Karjalainen, and J. Brauman Rapid reduction and removal of HDL- but not LDL-associated cholesteryl ester hydroperoxides by rat liver perfused in situ Biochem J 314 Pt 3 1996 739 742
7. A. Onat, and G. Hergenç Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk Metabolism 60 2011 499 512
8. P. Durrington Dyslipidaemia Lancet 362 2003 717 731
9. M.C. Carr, and J.D. Brunzell Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk J Clin Endocrinol Metab 89 2004 2601 2607
10. S. Tonstad, and J.-P. Després Treatment of lipid disorders in obesity Expet Rev Cardiovasc Ther 9 2011 1069 1080
11. G.A. Francis High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences Biochim Biophys Acta 1483 2000 217 235
12. R. Stocker, and J.F. Keaney Jr. Role of oxidative modifications in atherosclerosis Physiol Rev 84 2004 1381 1478
13. S. Tsimikas, and Y.I. Miller Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease Curr Pharm Des 17 2011 27 37
14. X. Jiang, Z. Yang, and A.N. Chandrakala Oxidized low density lipoproteins. Do we know enough about them? Cardiovasc Drugs Ther 25 2011 367 377
15. P. Viani, R. Cazzola, and G. Cervato Pyrene lipids as markers of peroxidative processes in different regions of low and high density lipoproteins Biochim Biophys Acta 1315 1996 78 86
16. H.J. Galla, and W. Hartmann Excimer-forming lipids in membrane research Chem Phys Lipids 27 1980 199 219
17. M. Vauhkonen, and P. Somerharju The surface lipid layer of human low density lipoprotein probed by dipyrenyl phospholipids Chem Phys Lipids 52 1990 207 216
18. D.R. Matthews, J.P. Hosker, and A.S. Rudenski Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
19. K.M. Oldham, and P.E. Bowen Oxidative stress in critical care: is antioxidant supplementation beneficial? J Am Diet Assoc 98 1998 1001 1008
20. R.W. James A long and winding road: defining the biological role and clinical importance of paraoxonases Clin Chem Lab Med 44 2006 1052 1059
21. M. Rosenblat, R. Karry, and M. Aviram Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes Atherosclerosis 187 2006 74 81
22. R. Cazzola, G. Cervato, and B. Cestaro Variability in alpha-tocopherol antioxidant activity in the core and surface layers of low- and high-density lipoproteins J Nutr Sci Vitaminol 45 1999 39 48
23. B.H. Chung, J.P. Segrest, and M.J. Ray Single vertical spin density gradient ultracentrifugation Methods Enzymol 128 1986 181 209
24. R. Cazzola, M. Rondanelli, and R. Trotti Effects of weight loss on erythrocyte membrane composition and fluidity in overweight and moderately obese women J Nutr Biochem 22 2011 388 392
25. M. Conti, P.C. Morand, and P. Levillain Improved fluorometric determination of malonaldehyde Clin Chem 37 1991 1273 1275
26. J.W. Heinecke, L. Baker, and H. Rosen Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells J Clin Invest 77 1986 757 761
27. T. Ohnishi, C. Tan, and S. Yokoyama Selective transfer of cholesteryl ester over triglyceride by human plasma lipid transfer protein between apolipoprotein-activated lipid microemulsions Biochemistry 33 1994 4533 4542
28. J.W. Skeggs, and R.E. Morton LDL and HDL enriched in triglyceride promote abnormal cholesterol transport J Lipid Res 43 2002 1264 1274
29. J.S. Parks, K.W. Huggins, and A.K. Gebre Phosphatidylcholine fluidity and structure affect lecithin:cholesterol J Lipid Res 41 2000 546 553
30. C. Dachet, C. Motta, and D. Neufcour Fluidity changes and chemical composition of lipoproteins in type IIa Biochim Biophys Acta 1046 1990 64 72
31. R. Cazzola, M. Rondanelli, and S. Russo-Volpe Decreased membrane fluidity and altered susceptibility to peroxidation and lipid composition in overweight and obese female erythrocytes J Lipid Res 45 2004 1846 1851
32. N.P. Morales, C. Charlermchoung, and R. Luechapudiporn Lipid fluidity at different regions in LDL and HDL of beta-thalassemia/Hb E patients Biochem Biophys Res Commun 350 2006 698 703
33. B. Garner, P.K. Witting, and A.R. Waldeck Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol J Biol Chem 273 1998 6080 6087
34. A.G. Rumley, M. Woodward, and A. Rumley Plasma lipid peroxides: relationships to cardiovascular risk factors and prevalent cardiovascular disease QJM 97 2004 809 816
35. A.A. Franke, P.J. Harwood, and T. Shimamoto Effects of micronutrients and antioxidants on lipid peroxidation in human plasma and in cell culture Cancer Lett 79 1994 17 26